| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.382 | 0.023 | 0.382 | Peroxidase inhibitor | 0.141 0.083 CID_154699813 | ||
| 0.36 | 0.005 | 0.377 | Succinate dehydrogenase inhibitor | 0.377 0.004 CID_154699813 | CID_154699813 | |
| 0.344 | 0.005 | 0.344 | MAP kinase kinase inhibitor | 0.282 0.01 CID_154699813 | ||
| 0.333 | 0.031 | 0.376 | 5 Hydroxytryptamine uptake stimulant | 0.376 0.019 CID_154699813 | CID_154699813 | |
| 0.265 | 0.013 | 0.272 | Cystathionine beta-synthase inhibitor | 0.272 0.012 CID_154699813 | CID_154699813 | |
| 0.228 | 0.005 | 0.228 | Death-associated protein kinase 1 inhibitor | 0.161 0.026 CID_154699813 | ||
| 0.316 | 0.105 | 0.365 | GABA C receptor rho-3 antagonist | 0.365 0.078 CID_154699813 | CID_154699813 | |
| 0.238 | 0.031 | 0.238 | Heat shock protein 90 alpha antagonist | 0.124 0.12 CID_154699813 | ||
| 0.195 | 0.005 | 0.195 | MAP kinase kinase 1 inhibitor | 0.193 0.005 CID_154699813 | ||
| 0.288 | 0.104 | 0.288 | Calcium channel activator | 0.273 0.12 CID_154699813 | ||
| 0.188 | 0.044 | 0.188 | Heat shock protein 90 antagonist | |||
| 0.243 | 0.099 | 0.243 | Immunostimulant | |||
| 0.161 | 0.021 | 0.161 | DNA directed RNA polymerase inhibitor | 0.106 0.05 CID_154699813 | ||
| 0.173 | 0.041 | 0.173 | MAP kinase 3 inhibitor | |||
| 0.18 | 0.058 | 0.18 | ATPase inhibitor | |||
| 0.137 | 0.016 | 0.137 | Nav1.8 sodium channel blocker | 0.104 0.026 CID_154699813 | ||
| 0.234 | 0.119 | 0.234 | 12-Lipoxygenase inhibitor | |||
| 0.309 | 0.201 | 0.309 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.309 0.2 CID_154699813 | ||
| 0.138 | 0.033 | 0.138 | UDP-glucose 4-epimerase inhibitor | 0.104 0.057 CID_154699813 | ||
| 0.215 | 0.111 | 0.215 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.113 | 0.011 | 0.113 | NMDA receptor glycine site agonist | 0.091 0.021 CID_154699813 | ||
| 0.171 | 0.072 | 0.171 | Phospholipase C inhibitor | 0.147 0.111 CID_154699813 | ||
| 0.183 | 0.089 | 0.183 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.171 0.106 CID_154699813 | ||
| 0.121 | 0.035 | 0.121 | NMDA receptor antagonist | |||
| 0.126 | 0.041 | 0.126 | Platelet activating factor alpha antagonist | |||
| 0.12 | 0.041 | 0.12 | Sphingomyelinase inhibitor | |||
| 0.102 | 0.026 | 0.108 | GABA aminotransferase inhibitor | 0.108 0.022 CID_154699813 | CID_154699813 | |
| 0.119 | 0.045 | 0.119 | Urease inhibitor | |||
| 0.167 | 0.093 | 0.167 | MAP kinase kinase 5 inhibitor | 0.151 0.147 CID_154699813 | ||
| 0.111 | 0.045 | 0.111 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.107 0.048 CID_154699813 | ||
| 0.089 | 0.024 | 0.089 | NMDA receptor agonist | 0.071 0.035 CID_154699813 | ||
| 0.12 | 0.06 | 0.12 | Transcription factor STAT6 inhibitor | |||
| 0.162 | 0.102 | 0.224 | Non-steroidal antiinflammatory agent | 0.224 0.055 CID_154699813 | CID_154699813 | |
| 0.101 | 0.043 | 0.101 | NADH dehydrogenase inhibitor | 0.088 0.059 CID_154699813 | ||
| 0.125 | 0.068 | 0.125 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.068 | 0.013 | 0.068 | Histone deacetylase 5 inhibitor | |||
| 0.137 | 0.084 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.146 0.053 CID_154699813 | CID_154699813 | |
| 0.073 | 0.022 | 0.073 | Botulinum neurotoxin type A inhibitor | |||
| 0.107 | 0.058 | 0.107 | 5-Lipoxygenase inhibitor | |||
| 0.068 | 0.019 | 0.068 | Dihydroorotate oxidase inhibitor | |||
| 0.083 | 0.036 | 0.083 | GABA B receptor agonist | 0.079 0.043 CID_154699813 | ||
| 0.057 | 0.01 | 0.057 | Histone deacetylase class II inhibitor | |||
| 0.096 | 0.051 | 0.096 | Triose-phosphate isomerase inhibitor | 0.082 0.072 CID_154699813 | ||
| 0.099 | 0.055 | 0.099 | HIV-1 integrase (Overall Integration) inhibitor | 0.08 0.078 CID_154699813 | ||
| 0.089 | 0.046 | 0.089 | D-Ala-D-Ala ligase inhibitor | 0.079 0.071 CID_154699813 | ||
| 0.075 | 0.036 | 0.075 | Bcl2 antagonist | |||
| 0.084 | 0.045 | 0.084 | ErbB-2 antagonist | |||
| 0.118 | 0.082 | 0.174 | Cyclooxygenase 1 inhibitor | 0.174 0.046 CID_154699813 | CID_154699813 | |
| 0.049 | 0.016 | 0.049 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.044 | 0.012 | 0.044 | Histone deacetylase class IIb inhibitor | |||
| 0.043 | 0.012 | 0.043 | Histone deacetylase 6 inhibitor | |||
| 0.046 | 0.015 | 0.046 | Histone deacetylase class IIa inhibitor | |||
| 0.122 | 0.092 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.086 CID_154699813 | CID_154699813 | |
| 0.048 | 0.023 | 0.048 | Glutamate (mGluR4) antagonist | |||
| 0.04 | 0.015 | 0.04 | ADAM10 endopeptidase inhibitor | |||
| 0.133 | 0.109 | 0.168 | Arachidonic acid antagonist | 0.168 0.067 CID_154699813 | CID_154699813 | |
| 0.122 | 0.098 | 0.122 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.099 | 0.077 | 0.105 | DOPA decarboxylase inhibitor | 0.105 0.066 CID_154699813 | CID_154699813 | |
| 0.039 | 0.018 | 0.039 | Histone deacetylase class IV inhibitor | |||
| 0.039 | 0.018 | 0.039 | Histone deacetylase 11 inhibitor | |||
| 0.056 | 0.035 | 0.056 | Immunoglobulin Fc receptor antagonist | |||
| 0.106 | 0.086 | 0.106 | c-Src kinase inhibitor | |||
| 0.088 | 0.068 | 0.088 | Glutamate release inhibitor | 0.083 0.082 CID_154699813 | ||
| 0.038 | 0.02 | 0.038 | Histone deacetylase 2 inhibitor | |||
| 0.035 | 0.018 | 0.035 | Histone deacetylase 10 inhibitor | |||
| 0.058 | 0.041 | 0.058 | Aminopeptidase microsomal inhibitor | |||
| 0.18 | 0.163 | 0.18 | Lipoxygenase inhibitor | |||
| 0.054 | 0.038 | 0.054 | GABA receptor antagonist | |||
| 0.019 | 0.005 | 0.019 | Human herpes virus 5 capsid protein P40 inhibitor | 0.013 0.008 CID_154699813 | ||
| 0.049 | 0.035 | 0.049 | Collagenase inhibitor | |||
| 0.066 | 0.054 | 0.08 | Exportin-1 inhibitor | 0.08 0.025 CID_154699813 | CID_154699813 | |
| 0.029 | 0.018 | 0.029 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.026 0.021 CID_154699813 | ||
| 0.073 | 0.062 | 0.073 | Estrogen receptor alpha antagonist | |||
| 0.027 | 0.016 | 0.027 | Histone deacetylase 1 inhibitor | |||
| 0.032 | 0.021 | 0.032 | ATP citrate lysase inhibitor | 0.031 0.024 CID_154699813 | ||
| 0.118 | 0.108 | 0.118 | Farnesoid X receptor antagonist | |||
| 0.035 | 0.027 | 0.035 | Ceramide glucosyltransferase inhibitor | |||
| 0.08 | 0.072 | 0.08 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.031 | 0.023 | 0.031 | Histone deacetylase 4 inhibitor | |||
| 0.094 | 0.087 | 0.094 | GABA C receptor antagonist | |||
| 0.045 | 0.038 | 0.045 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.055 | 0.048 | 0.055 | Collagenase 3 inhibitor | |||
| 0.049 | 0.042 | 0.049 | GABA A receptor antagonist | |||
| 0.024 | 0.018 | 0.024 | NMDA receptor glycine site antagonist | |||
| 0.101 | 0.096 | 0.101 | Glutamate receptor antagonist | |||
| 0.038 | 0.033 | 0.038 | CF transmembrane conductance regulator antagonist | |||
| 0.013 | 0.009 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.037 | 0.033 | 0.037 | Aggrecanase 1 inhibitor | |||
| 0.059 | 0.056 | 0.075 | Sphingosine 1-phosphate receptor 4 agonist | 0.075 0.041 CID_154699813 | CID_154699813 | |
| 0.084 | 0.083 | 0.084 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.121 | 0.122 | 0.143 | Sphingosine 1-phosphate receptor 5 antagonist | 0.143 0.074 CID_154699813 | CID_154699813 | |
| 0.239 | 0.243 | 0.288 | 5 Hydroxytryptamine release inhibitor | 0.288 0.179 CID_154699813 | CID_154699813 | |
| 0.021 | 0.025 | 0.03 | Kynurenine 3 monooxygenase inhibitor | 0.03 0.015 CID_154699813 | CID_154699813 | |
| 0.083 | 0.09 | 0.096 | Electrolyte absorption antagonist | 0.096 0.063 CID_154699813 | CID_154699813 | |
| 0.099 | 0.106 | 0.125 | Cyclooxygenase 2 inhibitor | 0.125 0.074 CID_154699813 | CID_154699813 | |
| 0.06 | 0.067 | 0.068 | Glutamate (mGluR6) antagonist | 0.068 0.043 CID_154699813 | CID_154699813 | |
| 0.065 | 0.077 | 0.088 | Macrophage migration inhibitory factor inhibitor | 0.088 0.043 CID_154699813 | CID_154699813 | |
| 0.103 | 0.121 | 0.138 | Cyclooxygenase inhibitor | 0.138 0.08 CID_154699813 | CID_154699813 | |
| 0.028 | 0.047 | 0.034 | Benzodiazepine receptor peripheral-type antagonist | 0.034 0.023 CID_154699813 | CID_154699813 | |
| 0.038 | 0.064 | 0.053 | Benzodiazepine antagonist | 0.053 0.022 CID_154699813 | CID_154699813 | |
| 0.159 | 0.185 | 0.179 | Nitric-oxide synthase stimulant | 0.179 0.13 CID_154699813 | CID_154699813 | |
| 0.119 | 0.15 | 0.188 | Pyruvate kinase inhibitor | 0.188 0.088 CID_154699813 | CID_154699813 | |
| 0.047 | 0.078 | 0.056 | Pregnane X receptor antagonist | 0.056 0.04 CID_154699813 | CID_154699813 | |
| 0.097 | 0.132 | 0.111 | Sphingosine 1-phosphate receptor 4 antagonist | 0.111 0.091 CID_154699813 | CID_154699813 | |
| 0.079 | 0.144 | 0.147 | Cyclooxygenase 3 inhibitor | 0.147 0.051 CID_154699813 | CID_154699813 | |
| 0.064 | 0.145 | 0.086 | Bile acid receptor antagonist | 0.086 0.083 CID_154699813 | CID_154699813 | |
| 0.045 | 0.241 | 0.085 | Thioredoxin inhibitor | 0.085 0.07 CID_154699813 | CID_154699813 | |
| 0.056 | 0.257 | 0.151 | Aryl hydrocarbon receptor agonist | 0.151 0.135 CID_154699813 | CID_154699813 | |
| 0.012 | 0.221 | 0.087 | Aldose reductase inhibitor | 0.087 0.021 CID_154699813 | CID_154699813 | |
| 0.075 | 0.601 | 0.35 | Antiinflammatory | 0.35 0.173 CID_154699813 | CID_154699813 | |
| 0.031 | 0.561 | 0.192 | Aurora-C kinase inhibitor | 0.192 0.022 CID_154699813 | CID_154699813 | |
| 0.005 | 0.86 | 0.16 | Topoisomerase I inhibitor | 0.16 0.038 CID_154699813 | CID_154699813 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |